Xiangpei Zhao

Xiangpei Zhao

Auto-generated profile, based on publicly available information

Xiangpei Zhao

Zhuang and Yao Medicine Research Laboratory, International Zhuang Medicine Hospital Affiliated to Guangxi University of Chinese Medicine, No. 8, Qiuyue Road, Wuxiang New Area, Liangqing District, Nanning, 530201, China; Minzu University of China,No. 27, Zhongguancun South Street, Haidian District, Beijing, 100081, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2023 in Gynecologic and Obstetric Investigation
Verified
Journal Article
Open access
PDF file
CZChuanmei Zhong
Chuanmei Zhong
GJGongchenhao Ju
Gongchenhao Ju
SYSufang Yang
Sufang Yang
XZXiangpei Zhao
Xiangpei Zhao
JCJixiang Chen
Jixiang Chen
NLNing Li
Ning Li
Objective: The objective of this study was to explore the inhibitory effect of total flavonoids of Polygala fallax Hemsl (PFHF) on human ectopic endometrial stromal cells (HEcESCs) and its mechanism. Design: The apoptosis, cell cycle, migration, and invasion ability of HEcESCs (Fresh human ovarian endometriosis tissue was used for primary culture) after PFHF treatment were detected, and the mechanism of action was explored. Materials: The Polygala fallax Hemsl (PFH), RPMI 1640 culture medium, Dulbecco’s modified Eagle’s medium (DMEM)/F-12, fetal bovine serum, penicillin/streptomycin, cell counting kit-8 (CCK-8) kit, trypsin, phenylmethylsulfonyl fluoride, radioimmunoprecipitation assay tissue/cell lysate, bicinchoninic acid protein concentration detection kits, protein loading buffer, the apoptosis and cell cycle extraction kits, the matrix glue, TRIzol Universal Reagent, the reverse transcription kit, AB HS Green qPCR Mix, the ECL chromogenic solution, enzyme labeling instrument, flow cytometry, automatic real-time fluorescence quantitative PCR instrument, Goat anti-rabbit, rabbit anti-β-actin, vimentin, phosphatidylinositol 3 kinase (PI3K), protein kinase B (AKT), B-cell lymphoma-2 (Bcl-2), Bcl-extra long (Bcl-xl), Bcl-2 associated death promoter (Bad) antibody, Alexa Fluor 594-labeled secondary antibody, the inverted microscope, the constant temperature carbon dioxide cell incubator. Setting: Five parts included introduction, materials and methods, results, discussion, and conclusion. Methods: The potential targets and pathways of PFHF in the treatment of endometriosis were predicted by network pharmacology. The effect of PFHF on the proliferation, apoptosis and cell cycle, migration, and invasion of HEcESCs was detected by CCK-8 method, flow cytometry, and Transwell chamber experiment. Label-free quantitative proteomics based on mass spectrometry was used to analyze the protein mass spectrum of differential expression of HEcESCs before and after PFHF, and the biological information was analyzed. The effects of PFHF on the mRNA and protein expression of pathway-related genes predicted in HEcESCs were detected by reverse transcription-quantitative polymerase chain reaction and Western blotting. Results: The network pharmacology predicts that PFHF treats endometriosis through PI3K/AKT signaling pathway. Compared with control group (DMEM/F-12 medium alone), the high dose PFHF can significantly reduce the viability, migration, and invasion of HEcESCs, increase the apoptosis rate of HEcESCs, and make the HEcESCs accumulated in G0/G1 phase in a time- and dose-dependent manner (p < 0.05). The analysis of label-free quantitative proteomics indicated that PFHF flavonoids may induce apoptosis of EESCs through PI3K/AKT signaling pathway. The results of RT-qPCR and Western blotting showed that the expressions of PI3K, AKT, Bcl-2, and Bcl-xl were significantly downregulated, while the bad expression was upregulated in HEcESCs treated with PFHF (p < 0.05). Limitations: This research investigated the effects of PFHF on the stromal endometriotic cells only. So it is unknown how PFHF can affect the entire endometriotic lesion. And the research is carried out in vitro, which gives no impression about the bioavailability of the flavonoids. Conclusion: PFHF reduces the expression of PI3K, AKT, Bcl-2, and Bcl-xl through the PI3K/AKT/Bcl-2 signaling pathway to inhibit HEcESCs proliferation, migration, and invasion and promote their apoptosis.

22 April 2024 in Journal of Proteome Research
Verified
Journal Article
Closed access
YLYan-Ping Li
Yan-Ping Li
ZHZi-Jia Huang
Zi-Jia Huang
QHQuan-Kuo He
Quan-Kuo He
YLYi-Xiang Li
Yi-Xiang Li
XZXiang-Pei Zhao
Xiang-Pei Zhao
CLChun-Hua Lu
Chun-Hua Lu

31 July 2024 in ACS Omega
Verified
Journal Article
Open access
XZXiangpei Zhao
Xiangpei Zhao
ZLZhaoyang Long
Zhaoyang Long
HZHua Zhong
Hua Zhong
RLRongping Lu
Rongping Lu
JWJuan Wei
Juan Wei
XSXi Zong Sun
Xi Zong Sun
Objectives: To examine the anti-inflammatory properties and underlying mechanisms of Tongfeng Li'an Granules (TFLA), a traditional medicine, in acute gouty arthritis using a rat model. Materials and Methods: We identified 55 major compounds in TFLA via ultrahigh-performance liquid chromatography connected to quadrupole time-of-flight mass spectrometry (UPLC-TQF-MS/MS). Databases were employed for the prediction of potential targets, followed by PPI network construction as well as GO and KEGG analyses. After network-pharmacology-based analysis, a rat gouty arthritis model was used to validate the anti-inflammatory mechanism of TFLA. Results: UPLC-TQF-MS/MS and network pharmacology analyses revealed 55 active ingredients and 160 targets of TFLA associated with gouty arthritis, forming an ingredient-target-disease network. The PPI network identified 20 core targets, including TLR2, TLR4, IL6, NF kappa B, etc. Functional enrichment analyses highlighted the Toll-like receptor signaling pathway as significantly enriched by multiple targets, validated in in vivo experiments. Animal experiments demonstrated that TFLA improved pathological changes in gouty joint synovium, with decreased ankle joint circumference, serum IL6, IL10, and TNF alpha levels, as well as reduced protein and mRNA expression of NLRP3, TLR2, and TLR4 in ankle joint synovial tissue observed in the middle- and high-dose TFLA and positive control groups compared to the model group (p < 0.05). Conclusion: This research elucidated the pharmacological mechanisms of TFLA against gouty arthritis, implicating various ingredients, targets, and signaling pathways. Animal experiments confirmed TFLA's efficacy in alleviating inflammation in acute gouty arthritis by modulating Toll-like receptor signaling and NLRP3 expression.

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
XZXiangpei Zhao
Xiangpei Zhao
JHJinchang Huang
Jinchang Huang
ZMZhenyu Mo
Zhenyu Mo
JWJiangcun Wei
Jiangcun Wei
CZChuanmei Zhong
Chuanmei Zhong
HTHongli Teng
Hongli Teng
The aim of the study is to examine the mechanism of Aralia armata (Wall.) Seem (AAS) in improving intimal hyperplasia after vascular injury in rats. Rats with femoral artery injury were randomly divided into three groups: the model group, AAS low‐dose group (40 mg/kg), and AAS high‐dose group (80 mg/kg). The sham operation group was used as a control group. HE staining was used to observe the changes in femoral artery vessels. Immunohistochemistry was adopted to detect α‐SMA, PCNA, GSK‐3β, and β‐catenin proteins in femoral artery tissue. The CCK‐8 test and wound healing assay were employed to analyze the effect of AAS on proliferation and migration of vascular smooth muscle cells (VSMCs) cultured in vitro. Western blotting (WB) and polymerase chain reaction (PCR) assays were used to evaluate the molecular mechanism. AAS reduced the stenosis of blood vessels and the protein expressions of α‐SMA, PCNA, GSK‐3β, and β‐catenin compared to the model group. In addition, AAS (0‐15 μg/mL) effectively inhibited the proliferation and migration of VSMCs. Moreover, the results of WB and PCR showed that AAS could inhibit the activation of β‐catenin induced by 15% FBS and significantly decrease the expression levels of Wnt3α, Dvl‐1, GSK‐3β, β‐catenin, and cyclin D1 in the upstream and downstream of the pathway. AAS could effectively inhibit the proliferation and migration of neointima after vascular injury in rats by regulating the Wnt/β‐catenin signaling pathway.

1 August 2020 in Journal of Biobased Materials and Bioenergy
Verified
Journal Article
Closed access
XZXiangpei Zhao
Xiangpei Zhao
SCShaofeng Chen
Shaofeng Chen
WZWen Zhong
Wen Zhong
HLHuachun Li
Huachun Li
SYShengmin Yu
Shengmin Yu
Plumbago zeylanica L. (PZ) is a folk medicine for liver damage. To further explore its mechanism of action, a rat model of liver injury induced by carbon tetrachloride (CCl4) was used to evaluate the protective effect of PZ water extract (PZE). The results showed that PZE normalized the CCl4-induced serum levels of liver function index, hyaluronic acid (HA), superoxide dismutase (SOD), malondialdehyde (MDA), and decreased the hydroxyproline (Hyp) level in liver tissue. PZE also reduced the histological injuries induced by CCl4. In conclusion, these data demonstrated the hepatoprotective activities of PZE that may be related to its antioxidant properties.

17 February 2026 in Journal of Ethnopharmacology
Verified
Journal Article
Open access
JSJieying Su
Jieying Su
MYMei Yang
Mei Yang
YZYang Zhou
Yang Zhou
TLTaijun Liu
Taijun Liu
DZDan Zhu
Dan Zhu
XZXiangpei Zhao
Xiangpei Zhao
Proteinuria is a key indicator and therapeutic difficulty in the progression of kidney diseases. Yingbupu (YBP), an ethnic medicine, has demonstrated significant proteinuria-lowering effects in folk applications, but its exact nephroprotective effects and molecular mechanisms are still unclear. To investigate the nephroprotective effect of YBP and its mechanism of action. UPLC-Q-Orbitrap HRMS technology was used to analyze the absorbed constituents of YBP, and integrated methods of network pharmacology, molecular docking, and adriamycin renal injury model rat experiments (observation of general indexes, urinary proteins, ultrastructure of renal tissues, immunohistochemistry, WB, and PCR) were used to evaluate the renoprotective effects and mechanisms of action of YBP. Twenty-four absorbed constituents were identified in YBP, and 136 key targets were screened. Enrichment analysis suggested that the Wnt/β-catenin signaling pathway might play a central role. Animal experiments confirmed that YBP could significantly improve renal injury and reduce urinary protein level, inhibit the reduction of β-catenin nuclear translocation, and significantly down-regulate the expression of target genes such as Cyclin D1 and Axin-2. The renoprotective effect of YBP can be attributed to its ability to effectively reverse the abnormal activation of Wnt/β-catenin pathway.